Presence of immunoreactive beta-endorphin in normal human plasma: a concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration.
about
Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.Beta endorphin release in patients after spontaneous and provoked acute myocardial ischaemia.Stress hormones in accident patients studied before admission to hospital.Beta endorphin selectively stimulates aldosterone secretion in hypophysectomized, nephrectomized dogs.Volume transmission of beta-endorphin via the cerebrospinal fluid; a reviewNeurohormones regulate T cell functionStress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation.beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits.Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis.Immunoreactive beta-endorphin and adrenocorticotropin in human cerebrospinal fluidAnalgesic action of acetaminophen in symptomatic osteoarthritis of the knee.Involvement of serotonin in the central control of opioid secretion.Biosynthesis and distribution of opioid peptides.In vitro lipolytic activity of porcine beta-endorphin not mediated by an opiate receptor.Plasma pro-opiomelanocortin fragments and adrenal steroids following administration of metyrapone to normal and hirsute women.Adrenocorticotropic hormone cells and immunoreactive beta-endorphin cells in the human pituitary gland: normal and pathologic conditions studied by the peroxidase-labeled antibody method.Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides?Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis.Effector mechanism and clinical response of BAK (BRM-activated killer) immuno-cell therapy for maintaining satisfactory QOL of advanced cancer patients utilizing CD56-positive NIE (neuro-immune-endocrine) cells.A triphasic pattern of parallel secretion of beta-endorphin/beta-lipotropin and ACTH after adrenalectomy in rats.Increase in plasma methionine-enkephalin levels during the pain attack in episodic cluster headache.
P2860
Q27311002-7EABC5F4-ECD1-42FB-ACDF-26D97295CACFQ33611756-F62B961F-5281-4E02-8F44-41FEC6F127BEQ34291679-8F3E6785-9676-4AB7-97D7-7042601191E5Q35202331-A80D2C61-5FDE-449A-96C2-DF6FA5ED08D1Q36226560-07D85939-3E44-41C7-8247-57676ED3B7DBQ36351097-41E7F602-0B01-4A8B-B6A4-B859FB5B29D1Q36354170-25162FE8-DB94-4D00-AC1B-613FC0EB373CQ36401374-150840AE-453C-4670-B950-16B1830EDF3CQ37025691-D0166836-0D68-4B16-81B1-AB303FF839F0Q37026840-F3058C64-7EE0-42BA-93E3-4D610838BF1BQ39355628-59C0AAD8-A60E-43E9-8F28-C9765652B443Q39485316-F9A2E36F-A842-4612-8427-B02DE5A5EE40Q40090486-222B74D4-3F98-416C-811A-FF43CD1EDEA2Q40237969-B8398F2B-40D2-4E37-91F7-4A98B286341FQ41336431-FD5B8D4F-C1A2-4FEC-B9EF-3044C204DDC9Q42051336-C1C4A4BB-EEFF-4A21-90C0-7047AE89E99CQ42123454-912B08C2-B885-4F9A-B2CE-F95DCF45A7CCQ42479546-3562F6EF-A455-4418-9A26-2FCA45EE486BQ43686865-5E21D363-8478-4C12-9035-0F66F4CDD603Q48790320-DD31E5F4-01F9-4008-9272-49BDFF8892D1Q48882853-9B9B64AC-7950-4B25-B66D-EA00A95CE0AB
P2860
Presence of immunoreactive beta-endorphin in normal human plasma: a concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Presence of immunoreactive bet ...... ter metyrapone administration.
@en
Presence of immunoreactive bet ...... ter metyrapone administration.
@nl
type
label
Presence of immunoreactive bet ...... ter metyrapone administration.
@en
Presence of immunoreactive bet ...... ter metyrapone administration.
@nl
prefLabel
Presence of immunoreactive bet ...... ter metyrapone administration.
@en
Presence of immunoreactive bet ...... ter metyrapone administration.
@nl
P2093
P2860
P356
P1476
Presence of immunoreactive bet ...... ter metyrapone administration.
@en
P2093
P2860
P304
P356
10.1172/JCI109261
P407
P577
1978-12-01T00:00:00Z